![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.65 | 4.52 | 4.99 | - | 189,060 | 10:52:51 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2020 12:53 | Would PHE allow a small scale approval for certain cases? | trinitygooner | |
31/7/2020 12:38 | We won't get a collective statement from regulators as they don't act together but in isolation. The most likely to hear from first is the MHRA but I wouldn't guarantee it. I wouldn't be surprised if the FDA trump (no pun intended) them just because they seem to be more on the ball at the moment! | ![]() nobbygnome | |
31/7/2020 12:32 | I do not think a formal phase 3 trial will be needed. Just a conditional approval with careful monitoring and reporting by clinicians. The SNG product was used recently in a home trial then there is already some good background evidence to suggest this is the case. Such is the human need and this treatment is very safe as shown by many global scientific papers over many years. I don't think its long until some sort of collective statement by regulators in this regard. I'm guessing sometime during the next 10 to 14 days we are supplying product to the masses. The only limit is how quickly we can supply the neb. kit and drug formulation. | ![]() elsol |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions